Cargando…
An exploratory study of metformin with or without rapamycin as maintenance therapy after induction chemotherapy in patients with metastatic pancreatic adenocarcinoma
Purpose: Metformin combined with the mTOR inhibitor rapamycin showed potential synergistic anti-tumor activity in preclinical studies in pancreatic ductal adenocarcinoma (PDA). This phase 1b study (NCT02048384) was conducted to evaluate the feasibility and activity of metformin +/– rapamycin in the...
Autores principales: | Bever, Katherine M., Borazanci, Erkut H., Thompson, Elizabeth A., Durham, Jennifer N., Pinero, Kimberly, Jameson, Gayle S., Vrana, Amber, Liu, Meizheng, Wilt, Cara, Wu, Annie A., Fu, Wei, Wang, Hao, Yin, Yafu, Leal, Jeffrey P., Jesus-Acosta, Ana De, Zheng, Lei, Laheru, Daniel A., Von Hoff, Daniel D., Jaffee, Elizabeth M., Powell, Jonathan D., Le, Dung T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260120/ https://www.ncbi.nlm.nih.gov/pubmed/32523648 http://dx.doi.org/10.18632/oncotarget.27586 |
Ejemplares similares
-
Rapamycin enhances survival in a Drosophila model of mitochondrial disease
por: Wang, Adrienne, et al.
Publicado: (2016) -
p53 and rapamycin are additive
por: Christy, Barbara, et al.
Publicado: (2015) -
Rapamycin maintains NAD(+)/NADH redox homeostasis in muscle cells
por: Zhang, Zhigang, et al.
Publicado: (2020) -
Rapamycin-induced miR-21 promotes mitochondrial homeostasis and adaptation in mTORC1 activated cells
por: Lam, Hilaire C., et al.
Publicado: (2017) -
Metformin alters skeletal muscle transcriptome adaptations to resistance training in older adults
por: Kulkarni, Ameya S., et al.
Publicado: (2020)